SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
    7.
    发明申请
    SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS 审中-公开
    作为治疗药物的替代药用乳胶

    公开(公告)号:WO2009132097A1

    公开(公告)日:2009-10-29

    申请号:PCT/US2009/041398

    申请日:2009-04-22

    IPC分类号: C07D409/06 A61K31/403

    CPC分类号: C07D409/06

    摘要: A compound comprising or a pharmaceutically acceptable salt thereof, or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.

    摘要翻译: 本文公开了包含其或其药学上可接受的盐或其前药的化合物。 Y,A和B如本文所述。 还公开了与这些化合物相关的方法,组合物和药物。

    SUBSTITUTED BETA-LACTAMS
    8.
    发明申请
    SUBSTITUTED BETA-LACTAMS 审中-公开
    替代BETA-LACTAMS

    公开(公告)号:WO2009111417A1

    公开(公告)日:2009-09-11

    申请号:PCT/US2009/035786

    申请日:2009-03-03

    发明人: OLD, David W.

    CPC分类号: C07D409/06

    摘要: Disclosed herein is a compound comprising a formula (F) or a pharmaceutically acceptable salt or a prodrug or a metabolite thereof; Y is (F) or (F) A is -(CHz)6-. cis -CH2CH=CH-(CH2)3-, or -CH2C≡C-(CH2)3-. wherein 1 or 2 carbon atoms may be substituted with S or O; or A is -(CH2)m-Ar-(CH2)o- wherein Ar is interarylene or heterointerarylene, the sum of m and o is from 1 to 4, and wherein one CH2 may be substituted with S or O; and D is aryl or heteroaryl. Used to treat glaucoma and baldness.

    摘要翻译: 本文公开了包含式(F)或其药学上可接受的盐或其前药或代谢物的化合物; Y是(F)或(F)A是 - (CHz)6-。 顺式-CH 2 CH = CH-(CH 2)3 - 或-CH 2 C = C-(CH 2)3 - 。 其中1或2个碳原子可以被S或O取代; 或A是 - (CH 2)m -Ar-(CH 2)o-,其中Ar是亚芳基或杂亚环烷基,m和o之和为1至4,并且其中一个CH 2可以被S或O取代; D是芳基或杂芳基。 用于治疗青光眼和秃发。

    THERAPEUTIC SUBSTITUTED CYCLOPENTANES FOR REDUCING INTRAOCULAR PRESSURE
    10.
    发明申请
    THERAPEUTIC SUBSTITUTED CYCLOPENTANES FOR REDUCING INTRAOCULAR PRESSURE 审中-公开
    用于减少心室压力的治疗性替代疗法

    公开(公告)号:WO2009006370A1

    公开(公告)日:2009-01-08

    申请号:PCT/US2008/068716

    申请日:2008-06-30

    摘要: Disclosed herein are compounds having formula (I) wherein a dashed line represents the presence or absence of a bond; Y is an organic acid functional group, or an amide or ester thereof; or Y is hydroxymethyl or an ether thereof; or Y is a tetrazolyl functional group; A is -(CH 2 ) 6 -, cis -CH 2 CH=CH-(CH 2 ) 3 -, or -CH 2 C=C-(CH 2 ) 3 -, wherein 1 or 2 carbon atoms may be replaced by S or O; or A is -(CH 2 ) m -Ar-(CH 2 ) o - wherein Ar is interarylene or heterointerarylene, the sum of m and o is 1, 2, 3, or 4, and wherein 1 -CH 2 - may be replaced by S or O, and 1 -CH 2 -CH 2 - may be replaced by -CH=CH- or -C≡C-; U 1 and U 2 are independently selected from -H, =O, -OH, -F, -Cl, and -CN; and B is aryl or heteroaryl, for use as acular hypotensive agent.

    摘要翻译: 本文公开了具有式(I)的化合物,其中虚线表示键的存在或不存在; Y是有机酸官能团,或其酰胺或酯; 或Y为羟甲基或其醚; 或Y为四唑基官能团; A是 - (CH 2)6 - ,顺式-CH 2 CH = CH-(CH 2)3 - 或-CH 2 C = C-(CH 2)3 - ,其中1或2个碳原子可被S或O取代; 或A是 - (CH 2)m -Ar-(CH 2)o-,其中Ar是亚芳基或杂亚环烷基,m和o的总和是1,2,3或4,并且其中1 -CH 2可以被S 或O和1 -CH 2 -CH 2 - 可以被-CH = CH-或-C = C-取代; U1和U2独立地选自-H,= O,-OH,-F,-Cl和-CN; 和B是芳基或杂芳基,用作眼压降低剂。